Physician profile
Xavier A Sanchez
NPI 1407117518
$15,398.27
in general payments reported to CMS, 2019-2025
32 companies · $1,469 in 2025
The $1,469 reported for 2025 was more than what 77% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,551 · 2020: $1,645 · 2021: $2,505 · 2022: $2,075 · 2023: $1,266 · 2024: $1,887 · 2025: $1,469.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,043 · Long Term Medical Supply Or Device Loan: $423 · Education: $156.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,043.48 |
| Long Term Medical Supply Or Device Loan | $423.11 |
| Education | $156.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Integra Lifesciences Corporation | $3,174.51 | 2019-2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Stryker Corporation | $2,535.84 | 2019-2025 | Prostep, Hoffmann, Salvation |
| Smith+Nephew, INC. | $1,656.11 | 2019-2025 | Collagenase Santyl, Versajet, Oasis |
| Southern Edge Orthopaedics, INC. | $1,409.00 | 2019 | |
| Organogenesis INC. | $1,036.88 | 2019-2025 | Affinity, Puraply Wound Matrix, Apligraf |
| Djo, LLC | $862.97 | 2019-2025 | Cmf |
| Arthrex, INC. | $801.76 | 2020 | |
| Treace Medical Concepts, INC. | $564.90 | 2022-2025 | |
| Flower Orthopedics Coporation | $480.77 | 2019-2021 | |
| Acera Surgical, INC. | $313.14 | 2021-2024 | Restrata Wound Matrix |
| Polynovo North America LLC | $308.34 | 2025 | Novosorb Btm |
| Paratek Pharmaceuticals, INC. | $246.91 | 2023-2024 | Nuzyra |
| Depuy Synthes Sales INC. | $185.33 | 2022 | |
| Amgen INC. | $174.97 | 2025 | Krystexxa |
| Kerecis Limited | $159.65 | 2021-2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Wright Medical Technology, INC. | $158.97 | 2019 | |
| Terumo Bct, INC. | $148.85 | 2022 | |
| Crossroads Extremity Systems, LLC | $145.81 | 2020 | |
| Biotissue Holdings INC. | $140.04 | 2022 | |
| Horizon Therapeutics Plc | $119.79 | 2021 | |
| Osiris Therapeutics INC. | $119.47 | 2019 | |
| Pacira Pharmaceuticals Incorporated | $110.91 | 2021-2022 | |
| Biocomposites INC | $104.53 | 2025 | Stimulan |
| Globus Medical, INC. | $100.84 | 2024 | Allocate, Precice Intramedullary Limb Lengthening System |
| Zimmer Biomet Holdings, INC. | $92.19 | 2023 | Sternalock 360 System |
| Cardiovascular Systems INC. | $83.44 | 2019 | |
| Boston Scientific Corporation | $56.48 | 2021 | |
| Bioventus LLC | $33.15 | 2020-2021 | |
| Ibsa Pharma INC. | $24.03 | 2023 | Tirosint, Licart |
| Abbott Laboratories | $23.11 | 2020 | |
| Paragon 28, INC. | $18.09 | 2023 | Monkey Rings |
| Ossdsign USA Incorporated | $7.49 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Xavier Sanchez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.